Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice

Current Developments in Nutrition
Laura M BeaverEmily Ho

Abstract

Cruciferous vegetables have been associated with the chemoprevention of cancer. Epigenetic regulators have been identified as important targets for prostate cancer chemoprevention. Treatment of human prostate cancer cells with sulforaphane (SFN), a chemical from broccoli and broccoli sprouts, inhibits epigenetic regulators such as histone deacetylase (HDAC) enzymes, but it is not known whether consumption of a diet high in broccoli sprouts impacts epigenetic mechanisms in an in vivo model of prostate cancer. In the transgenic adenocarcinoma of the mouse prostate (TRAMP) model, we tested the hypothesis that a broccoli sprout diet suppresses prostate cancer, inhibits HDAC expression, alters histone modifications, and changes the expression of genes regulated by HDACs. TRAMP mice were fed a 15% broccoli sprout or control AIN93G diet; tissue samples were collected at 12 and 28 wk of age. Mice fed broccoli sprouts had detectable amounts of SFN metabolites in liver, kidney, colon, and prostate tissues. Broccoli sprouts reduced prostate cancer incidence and progression to invasive cancer by 11- and 2.4-fold at 12 and 28 wk of age, respectively. There was a significant decline in HDAC3 protein expression in the epithelial cells of pros...Continue Reading

References

Apr 1, 1989·Journal of Clinical Pathology·P N BrawnD L Kuhl
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·N M GreenbergJ M Rosen
Jul 1, 1996·Toxicologic Pathology·J R Gingrich, N M Greenberg
Aug 15, 2000·Molecular Carcinogenesis·Q S WangD W Rosenberg
Mar 13, 2001·Seminars in Cancer Biology·S H Ali, J A DeCaprio
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Dec 21, 2006·Cancer Research·Shannon R MoreyAdam R Karpf
Feb 24, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jane V HigdonRoderick H Dashwood
Aug 23, 2008·Science·Gregory A HorwitzArnold J Berk
Dec 6, 2008·Digestive Diseases and Sciences·Hassan AshktorabDuane Smoot
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Angela GibbsJoshi Alumkal
Nov 16, 2010·Cancer Cell·Srividya BhaskaraScott W Hiebert
Jul 1, 1996·Urologic Oncology·N M Greenberg
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 18, 2011·Pharmaceutical Research·John D ClarkeEmily Ho
Nov 30, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Ben LiuLiping Xie
Feb 19, 2013·Biochemical Pharmacology·Chengyue ZhangAh-Ng Tony Kong
Mar 14, 2013·Molecular Oncology·Maxime Parisotto, Daniel Metzger
Jun 19, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Praveen RajendranRoderick H Dashwood
Apr 3, 2014·Cold Spring Harbor Perspectives in Biology·Edward Seto, Minoru Yoshida
Feb 26, 2015·Cancer Prevention Research·Kozue SakaoShivendra V Singh
Oct 30, 2015·Cancer Prevention Research·Lauren L AtwellJackilen Shannon
Dec 9, 2015·Experimental Biology and Medicine·Gregory W WatsonEmily Ho
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.